In the first part of this article we described how obesity in children is measured, its prevalence, whether children should be screened, and the risk factors for and consequences of obesity. 1 In this part we review the current evidence on the prevention and management of childhood obesity.
Can obesity be prevented?
A meta-analysis and Cochrane systematic review of controlled interventions to prevent childhood obesity published up to 2005 identified 61 and 22 studies, respectively. 2 3 Most studies found no strong evidence that interventions prevented weight gain or obesity, and many studies were limited in design, duration, or analysis. An update of the Cochrane review will be published in 2009.
The 2005 Cochrane review concluded that comprehensive strategies that deal with diet and physical activity, interventions with psychosocial support, and those that involved environmental change may help prevent obesity. The meta-analysis concluded that most (79%) of the large number of trials aimed at preventing childhood obesity found no effect on weight gain. The investigators pooled all studies (despite the varied types of intervention and populations) in one large meta-analysis and found a "trivial" beneficial effect on average, but marked heterogeneity between studies.
In contrast to these broad reviews of all interventions, a systematic review of controlled studies with interventions to reduce sedentary activities found that such interventions consistently reduced weight in children. 4 A systematic review of controlled trials to promote physical activity found some evidence of effect on activity levels for environmental interventions and those targeted at children from low socioeconomic backgrounds. 5 Multicomponent interventions (interventions involving school or education, family, the environment, or policy changes) increased physical activity in adolescents.
The modest effectiveness of programmes aimed at individual change to prevent obesity is similar to that found for other health behaviours. 2 Little research has evaluated the effect of interventions at the societal and political levels to prevent obesity.
SOURCES AND SELECTION CRITERIA
This review draws on the Foresight report, guidance from the National Institute for Health and Clinical Excellence and the Australian National Health Medical Research Council, and Cochrane review. In April 2008 we searched the Cochrane Library database of reviews and the Centre for Reviews and Dissemination databases using the search term "obesity". We also conducted a Medline search ((Child$ or paediatric or pediatric or adolescent) and (Obes$ or overweight)) limited to 1 January 2005 to 6 May 2008 and "review articles"; this identified 1105 articles. We read the abstracts of these articles and retrieved relevant papers. We also used articles from our own bibliographies collected over the past 10 years. The evidence to support the measurement, prevention, and management of obesity in children is still relatively weak, with few randomised controlled trials or systematic reviews. The strength of evidence is developing and the updated Cochrane review that will be published in 2009 may provide more compelling evidence for some interventions.
TIPS FOR NON-SPECIALISTS
Start by determining the extent of overweight and then assess the child for lifestyle, comorbidities, and willingness to change Advise children and families to increase physical activity, improve eating behaviour, and eat more healthily. The figure provides ideal levels of activity and recommendations for healthy eating in children. The NICE quick reference guide on obesity provides recommendations on methods for promoting these changes 8 Consider referral to any available community programmes Refer children with serious comorbidity or complex needs such as learning difficulties to secondary care paediatricians
The French EPODE ("ensemble, prévenons l'obé-sité des enfants" or "together, let's prevent obesity in children") programme has worked with families of children aged 5-12 years in 10 towns since 2004 with the aim of tackling obesity. 6 The programme involves communities in education, nutrition, and physical activity initiatives. EPODE has not been formally evaluated, but it has been adopted by the European Commission, and an EPODE European network has been established.
Policies to promote healthy eating and physical activity in schools are in place in several countries. Examples of such programmes are the National School Lunch Program in the United States and the Healthy Schools Programme in England. As with EPODE, the effect of these policies on obesity has not been evaluated. Reviews of the emerging evidence suggest that "walkable" neighbourhoods are associated with higher levels of physical activity, but there is less evidence to show links between the environment, physical activity, and obesity (A Tsouros and C Hall, personal communication).
The English cross government "healthy weight, healthy lives" strategy aims to reverse the trend in rising childhood obesity so that levels return to those of 2000 by 2020.
7 Box 1 summarises the components of the strategy. A social marketing campaign-"change4-life"-will start in England in 2008. The UK National Institute for Health and Clinical Excellence (NICE) guidelines for obesity include recommendations for the public, health professionals, preschool settings, schools, and local authorities (box 2). 8 When should interventions to prevent childhood obesity begin?
The question of when prevention should begin has to consider when increased risk for major diseases associated with obesity is established and whether it is easier to prevent obesity at some ages rather than others. We know that childhood adiposity is related to adult cardiovascular disease 9 and that childhood adiposity tracks into adulthood. 10 Greater adiposity in children has been associated with adverse metabolic risk profiles assessed at the same age; more recently, these cross sectional associations have also been found at birth-infants who have more fat tissue (particularly visceral fat) at birth have a higher fasting insulin and adverse lipid profiles at that time. 11 We also know that intrauterine factors, such as maternal gestational diabetes, are associated with increased body mass index (BMI). 12 But we do not know if the association of childhood adiposity with adult cardiovascular disease risk is fully explained by the tracking of childhood adiposity with adiposity in adulthood, or if the 
QUESTIONS FOR FUTURE RESEARCH AND ONGOING RESEARCH
Questions for future research What methods are most appropriate for preventing obesity at different ages? Studies should try to ascertain which interventions work best at different ages What type, level of intensity, and duration of preventive interventions (individual, family, or school based) are effective and cost effective in preventing obesity? Randomised controlled trials are needed of interventions that are theory driven and have had previous feasibility and pilot studies Are brief interventions in primary care effective in promoting a healthy diet, increasing physical activity, and reducing sedentary activities to prevent or reduce childhood obesity?
What are the most clinically effective and cost effective community based interventions for treating childhood obesity?
What is the long term clinical effectiveness and cost effectiveness of drug treatments in children?
What are the side effects of drug treatment and adherence in children at different ages?
Ongoing research A prospective longitudinal study of adolescents having bariatric surgery (Teen-longitudinal Assessment of Bariatric Surgery, TABS) in the US aims to estimate the risks and benefits of bariatric surgery in adolescence metabolic risks associated with obesity in infancy and childhood are reversible. The association of obesity with adverse outcomes at all ages has led most policy makers to aim to prevent obesity at all ages.
How can obesity be treated? Much of the evidence on the treatment of obesity comes from studies of children who are extremely obese. Changes in weight (and BMI) can seem dramatic for interventions in this population compared with the general population because such children can lose large amounts of weight more easily than those in the "normal" weight range. However, such weight losses in extremely obese children may not equate to achieving a healthy weight. Interventions that are effective at treating extreme childhood obesity cannot be assumed to be suitable for treating more modest overweight or for preventing obesity. Many countries have developed guidelines for managing childhood obesity; differences in these reflect variations in the structure of health services, resources, culture, and behaviours between countries. The further educational resources section has links to guidelines from the US and Australia. 13 14 How can non-specialists treat obese children? The NICE clinical guidelines provide recommendations for non-specialist clinicians (figure). Non-specialists should offer interventions to increase physical activity and encourage children and their families to eat healthily (figure). 15 The NICE quick reference guide for the NHS gives further advice about the type of interventions that are appropriate. 8 What community programmes can non-specialists refer to? Before considering referral to secondary care, it may be appropriate to consider community based treatment programmes. MEND (mind, exercise, nutrition . . . do it!) is the only programme provided nationwide in the United Kingdom. MEND is a twice weekly 10 week course for groups of children aged 7-13 and their parents. The course covers physical activity, behaviour change, and nutrition. To be included, children must be on or above the 91st to the 98th BMI centile (criteria vary locally). The full evaluation of MEND has yet to be published, but early data indicate that the programme has some promise as a means of reducing BMI, with the pilot evaluation reporting an average reduction of 0.24 BMI z scores. 17 Children who attended the Carnegie International Camp in Leeds (England) for a mean of 29 days lost 6.0 kg on average, reduced their BMI by a mean of 2.4 units, and reduced their BMI standard deviation scores by a mean of 0.28. 18 Two free living comparison groups of overweight and normal weight children showed increases in many of these measures. This intervention needs to be evaluated by a randomised controlled trial and a cost effectiveness study. WATCH IT is a community based obesity programme provided in sports centres in Leeds, which provides individual 19 The Care of Childhood Obesity programme in Bristol is a hospital based multidisciplinary service, which is being piloted for use in the community before full evaluation. 20 Commissioners of health services face several challenges in deciding what community services they need to commission to treat obese children. Because the current number of obese children is large, treating all of them is probably beyond the capacity of secondary care. The costs of implementing community based programmes, such as those described above, need to be considered against the long term health costs of no treatment. Although there is pressure for immediate action the current evidence, particularly on cost effectiveness, is limited. Where effectiveness has been demonstrated in the short term it is difficult to know which intervention is best, and randomised comparisons of different community based programmes would be useful.
When should children be referred? Different countries have different guidelines on when children should be referred and who they should be referred to-for example, paediatric endocrinologists, general paediatricians, dietitians, psychologists, or multidisciplinary teams. The NICE clinical guideline recommends referral to secondary care specialists if the child has serious comorbidities or complex needs, such as learning difficulties. 8 What drug treatment is recommended for children? Systematic reviews of randomised controlled trials in adults have shown that drugs are effective at reducing weight and associated metabolic complications, although adults do not adhere well to long term • Increasing physical activity to at least 60 minutes a day of moderate activity, which can be in 10 minute sessions; reducing sedentary activities; increasing structured activity and daily exercise • Improving eating behaviour. Interventions should be individualised, age appropriate, and aimed at reducing total energy intake to below expenditure, without using unduly restrictive diets 
Surgery
Surgery is not generally recommended for children or young people Consider surgery for young people only in exceptional circumstances, and if:
• They have achieved or nearly achieved physiological maturity • They have a BMI >40, or a BMI between 35 and 40 and other disease (for example, type 2 diabetes, high blood pressure) that might improve if they lost weight • All appropriate non-surgical measures have failed to achieve or maintain adequate clinically beneficial weight loss for at least 6 months • They are receiving or will receive intensive specialist management • They are generally fit for anaesthesia and surgery • They commit to the need for long term follow-up Guidance is provided on further discussions, assessment, medical evaluation, and choice of intervention Summarised National Institute for Health and Clinical Excellence guidelines for management of overweight and obesity in children. 8 The BMJ clinical review of breast feeding indicates that in 2009 the 2006 WHO growth charts will need to be used for babies from 2 weeks to 2 years 16 treatment with orlistat and sibutramine. 21 A nonsystematic review summarised the effect of drug treatment in children and noted a mean reduction of BMI in obese adolescents of −0.86 for orlistat, −2.8 for sibutramine, and −1.38 for metformin. 22 Treatment with orlistat or sibutramine is not recommended by NICE for children younger than 12 years unless the circumstances are exceptional. 8 It is recommended for children aged 12 years and over if they have physical or severe psychological comorbidities, and only after dietary, exercise, and behavioural approaches have been started and evaluated (figure). NICE recommends that treatment be started in secondary care (not in primary care) for six to 12 months and monitored regularly (frequency not specified in guidance) by a multidisciplinary team with expertise in drug monitoring, psychological support, and behavioural interventions. In the US, the Food and Drug Administration has approved sibutramine for patients aged 16 or more and orlistat for those aged 12 or more. 13 Rimonabant was approved for treating obesity in adults in Europe in 2006, but it was not included in the NICE review of obesity. A meta-analysis of randomised trials suggests that the drug might increase the risk of psychiatric adverse events in patients with no previous history. 23 A Cochrane review evaluated the use of rimonabant in adults and concluded that more rigorous studies of efficacy and safety were needed. 24 In the US, the Food and Drug Administration has requested further safety data before making a licensing decision. The UK Medicines and Healthcare Products Regulatory Agency and Commission on Human Medicines reported in May 2008 that insufficient data are available to assess the risk for children under 18 years.
When is bariatric surgery recommended for children? The two bariatric surgical approaches used for adolescents are Roux en Y gastric bypass (the more commonly performed procedure in the US) and laparoscopic adjustable gastric banding (the more commonly performed procedure in Europe and Australia). 25 In the US, the annual number of bariatric procedures carried out in adolescents increased five times between 1997 and 2003. 26 Case series of young people in Australia and the US report that, although surgery has considerable risks, larger decreases in BMI (in the order of 20.7 (37%)) 27 and greater improvements in some metabolic markers are achieved with surgery than with non-surgical methods. 25 Although surgery is not generally recommended by NICE for obese children or young people, it should be considered in exceptional circumstances if certain conditions are met (figure).
What does the future hold?
The recent Foresight report for the UK government suggested that a substantial increase in food or fuel prices, such as precipitated by climate change, might be the only scenario in which a spontaneous reversal of obesity would occur. 28 Otherwise, the Foresight report argues that a paradigm shift at societal and government levels is needed. If this shift does not occur, it is predicted that by 2050 the prevalence of obesity in under 20 year olds will be 25% in the UK. 28 Contributors: All authors discussed the scope and approach to the review. RRK drafted the review. All authors helped write the paper. All authors are guarantors. Competing interests: None declared. Provenance and peer review: Commissioned; externally peer reviewed.
SUMMARY POINTS
Few obesity prevention interventions have been shown to be effective in children Comprehensive strategies that tackle diet and physical activity as well as providing psychosocial support and environmental change may help prevent obesity Community based interventions aimed at changing activity levels, dietary knowledge, and eating behaviour may be useful but need evaluation for effectiveness and cost effectiveness Specialist treatment may include treatment with sibutramine or orlistat in children over 12, although long term studies are needed Surgery is recommended only in adolescents with extreme obesity, in limited circumstances, but the benefits need to be balanced against the possible side effects What types of article does the BMJ consider?
We are delighted to receive articles for publication-from doctors and others-on the clinical, scientific, social, political, and economic factors affecting health. We give priority to articles that will help doctors to make better decisions. Please see our advice to authors at http:// resources.bmj.com/bmj/authors, and if you would like to submit an article do so via our online editorial office at http://submit.bmj.com.
All original research articles are submitted, although we may invite submission (without promising acceptance) if we come across research being presented at conferences, if we see it in abstract form, or if the authors make an inquiry about the suitability of their work before submission.
We are also pleased to consider submitted articles for sections which carry a mix of commissioned and submitted articles-editorials, analysis, clinical review, practice, fillers, and Career Focus. Please follow the specific advice on each of these article types (see http:// resources.bmj.com/bmj/authors/types-of-article) before submitting your article. Some types of article-news, features, observations, head to head, views and reviewsare commissioned by the editors.
